N-(2-(4-Ethylphenylamino)benzo[d]oxazol-5-yl)-3-fluoro-5-(trifluoromethyl)benzamide

ID: ALA4075468

Chembl Id: CHEMBL4075468

PubChem CID: 54765634

Max Phase: Preclinical

Molecular Formula: C23H17F4N3O2

Molecular Weight: 443.40

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCc1ccc(Nc2nc3cc(NC(=O)c4cc(F)cc(C(F)(F)F)c4)ccc3o2)cc1

Standard InChI:  InChI=1S/C23H17F4N3O2/c1-2-13-3-5-17(6-4-13)29-22-30-19-12-18(7-8-20(19)32-22)28-21(31)14-9-15(23(25,26)27)11-16(24)10-14/h3-12H,2H2,1H3,(H,28,31)(H,29,30)

Standard InChI Key:  JDWBQVROLBTLAE-UHFFFAOYSA-N

Associated Targets(Human)

IL6 Tclin Interleukin-6 (43 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 443.40Molecular Weight (Monoisotopic): 443.1257AlogP: 6.54#Rotatable Bonds: 5
Polar Surface Area: 67.16Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.30CX Basic pKa: CX LogP: 6.51CX LogD: 6.51
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.34Np Likeness Score: -1.76

References

1. Kim D, Won HY, Hwang ES, Kim YK, Choo HP..  (2017)  Synthesis of benzoxazole derivatives as interleukin-6 antagonists.,  25  (12): [PMID:28442260] [10.1016/j.bmc.2017.03.072]

Source